Apple Watch availability threatened by court case loss
Masimo defines itself as an OEM that provides, among other devices, "hospital-grade" wearables that uses SET pulse oximetry tech for "accurate, actionable health insights".
The Apple Watch has also supported a similar feature since 2020 - which, as the "professional health" company asserts, is far too much of a coincidence.
To this end, Masimo has been pursuing legal action against Apple, asserting that the Cupertino behemoth used one of its "pulse oximeter patents" without permission.
The former has just posted a win in this case, as a Washington, D.C. Administrative Law Judge has ruled that Tim Cook's company is indeed guilty of this infringement.
Masimo notes that it is "happy" with this decision, although it does nothing to Apple's Watch business - yet.
However, the case will now be referred to the US International Trade Commission (USITC), a body that will determine whether the allegedly stolen technology makes the series 6 and its successors ineligible to import in the future.
